Literature DB >> 24790517

What do we know about metabolic syndrome in adolescents with PCOS?

Derya Akdağ Cırık1, Berna Dilbaz1.   

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive-aged women that manifests itself with a variety of features. For this reason, three different diagnostic criteria have been introduced. For adults, the National Institutes of Health Conference (NIH) criteria, which consists of hyperandrogenism and oligo-anovulation, is the most widely used. Symptoms of PCOS usually start with puberty and may overlap with normal pubertal development. Hormonal fluctuations during this period make the diagnosis of PCOS more difficult. Until now, there is no validated diagnostic criteria for PCOS in adolescents. Although menstrual disorders and cosmetic problems are the most common complaints of adolescents with PCOS, patients should also be evaluated for the potential risk for insulin resistance, obesity, subclinical atherosclerosis, diabetes, metabolic syndrome and cardiovascular disease. Obesity is the most prominent predictor of metabolic syndrome. As the incidence of obesity is increasing both in childhood and adolescence, governments will be faced with a social and economic burden in the future. Adolescents with PCOS are more obese than normal adolescents and have an increased risk of metabolic syndrome. It is suggested that abdominal adiposity increases the risk of metabolic syndrome by inducing various cytokine secretions. Although there is no consensus on metabolic syndrome criteria in the adolescent period, International Diabetes Federation (IDF) criteria may be used for children older than 10 years. Various clinical and metabolic markers are investigated for the prediction of metabolic syndrome in the literature. Waist circumference, serum triglycerides and androgens are the suspected predictors of metabolic syndrome. The prevention of abdominal adiposity and the early diagnosis of PCOS in adolescence should be the main target for the prevention of metabolic syndrome. Clinicians should investigate adolescents with PCOS for metabolic and cardiovascular risks and take preventive action. A Mediterranean diet, low in fat and high in fruits and vegetables, along with moderate-intensity exercise and smoking cessation are the recommended interventions for especially obese adolescents with PCOS. Metformin may be the treatment of choice when lifestyle modifications are ineffective.

Entities:  

Keywords:  Polycystic ovary syndrome; adolescent; metabolic syndrome

Year:  2014        PMID: 24790517      PMCID: PMC4004304          DOI: 10.5152/jtgga.2014.95776

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  52 in total

Review 1.  Inflammation and the etiology of type 2 diabetes.

Authors:  Ake Sjöholm; Thomas Nyström
Journal:  Diabetes Metab Res Rev       Date:  2006 Jan-Feb       Impact factor: 4.876

2.  Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.

Authors:  Roger Hart; Dorota A Doherty; Trevor Mori; Rae-Chi Huang; Robert J Norman; Stephen Franks; Deborah Sloboda; Lawrie Beilin; Martha Hickey
Journal:  Fertil Steril       Date:  2011-03-29       Impact factor: 7.329

3.  Relationship of adolescent polycystic ovary syndrome to parental metabolic syndrome.

Authors:  Natasha I Leibel; Elizabeth E Baumann; Masha Kocherginsky; Robert L Rosenfield
Journal:  J Clin Endocrinol Metab       Date:  2006-01-31       Impact factor: 5.958

4.  Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls.

Authors:  Dorte Glintborg; Marianne Andersen; Claus Hagen; Jan Frystyk; Veronica Hulstrøm; Allan Flyvbjerg; Anne Pernille Hermann
Journal:  Eur J Endocrinol       Date:  2006-08       Impact factor: 6.664

Review 5.  Intra-ovarian roles of activins and inhibins.

Authors:  Phil G Knight; Leanne Satchell; Claire Glister
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

Review 6.  The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.

Authors:  Ricardo Azziz; Enrico Carmina; Didier Dewailly; Evanthia Diamanti-Kandarakis; Héctor F Escobar-Morreale; Walter Futterweit; Onno E Janssen; Richard S Legro; Robert J Norman; Ann E Taylor; Selma F Witchel
Journal:  Fertil Steril       Date:  2008-10-23       Impact factor: 7.329

7.  Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.

Authors:  Katherine Esposito; Raffaele Marfella; Miryam Ciotola; Carmen Di Palo; Francesco Giugliano; Giovanni Giugliano; Massimo D'Armiento; Francesco D'Andrea; Dario Giugliano
Journal:  JAMA       Date:  2004-09-22       Impact factor: 56.272

8.  Follistatin and activins in polycystic ovary syndrome: relationship to metabolic and hormonal markers.

Authors:  Helena Teede; Sze Ng; Mark Hedger; Lisa Moran
Journal:  Metabolism       Date:  2013-06-12       Impact factor: 8.694

9.  Relationship of insulin receptor substrate-1 and -2 genotypes to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Xu Tang; Issei Yoshiuchi; Nancy J Cox; Graeme I Bell
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

10.  Association between polycystic ovarian syndrome, overweight, and metabolic syndrome in adolescents.

Authors:  Haleh Rahmanpour; Leila Jamal; Seyed Nouraddin Mousavinasab; Abdolreza Esmailzadeh; Kamran Azarkhish
Journal:  J Pediatr Adolesc Gynecol       Date:  2012-06       Impact factor: 1.814

View more
  12 in total

Review 1.  PCOS in adolescence and type 2 diabetes.

Authors:  Anne-Marie Carreau; Jean-Patrice Baillargeon
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  The association between androgen receptor gene CAG polymorphism and polycystic ovary syndrome: a case-control study and meta-analysis.

Authors:  Cui Ying Peng; Hui Jun Xie; Zi Fen Guo; Yu Lin Nie; Jun Chen; Jun Mei Zhou; Jie Yin
Journal:  J Assist Reprod Genet       Date:  2014-07-02       Impact factor: 3.412

3.  Obesity is not associated with the poor pregnancy outcome following intracytoplasmic sperm injection in women with polycystic ovary syndrome.

Authors:  Funda Akpınar; Berfu Demir; Serdar Dilbaz; Iskender Kaplanoğlu; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

4.  Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model.

Authors:  Wenhui Liu; Wenpei Liu; Yuling Fu; Yan Wang; Yuanzhen Zhang
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

Review 5.  Impact of obesity on infertility in women.

Authors:  Zeynep Özcan Dağ; Berna Dilbaz
Journal:  J Turk Ger Gynecol Assoc       Date:  2015-06-01

6.  Predictors of pregnancy after intrauterine insemination in women with polycystic ovary syndrome.

Authors:  Hui-Juan Guan; Lin-Qing Pan; Hang Song; Huai-Yun Tang; Li-Sha Tang
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 7.  Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome.

Authors:  Abm Kamrul-Hasan; Fatema Tuz Zahura Aalpona; Shahjada Selim
Journal:  touchREV Endocrinol       Date:  2021-04-28

8.  Index of orthodontic treatment need in obese adolescents.

Authors:  Maria Rita Giuca; Marco Pasini; Silvia Caruso; Simona Tecco; Stefano Necozione; Roberto Gatto
Journal:  Int J Dent       Date:  2015-04-05

9.  Correlation of Vitamin D with metabolic parameters in polycystic ovarian syndrome.

Authors:  Arun Kumar; Satish Barki; Vinod Raghav; Ashutosh Chaturvedi; K V S Hari Kumar
Journal:  J Family Med Prim Care       Date:  2017 Jan-Mar

10.  The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome.

Authors:  Marzieh Akbarzadeh; Tahereh Naderi; Mohammad H Dabbaghmanesh
Journal:  J Res Med Sci       Date:  2019-08-28       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.